// App-Quantinova.ai

1545 : Diagnostic Accuracy of a Defined Immunophenotypic and Molecular Genetic Approach for Peripheral T/NK-Cell Lymphomas: A North American PTCL Study Group Project

Researchers

Presenter

  • Jonathan Said

Principal Investigators

  • William R Macon

  • Scott J. Rodig

  • Randy D. Gascoyne

  • Sarah Ondrejka

  • David Dorfman

  • Elizabeth A. Morgan

  • Matthew J Maurer

  • Ahmet Dogan

Medical Centers

  • College of Medicine, Mayo Clinic, Rochester, MN

  • Department of Medicine, Brigham and Women's Hospital, Boston, MA

  • Department of Medical Oncology, BC Cancer Agency Center for Lymphoid Cancer, Vancouver, BC, Canada

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Peripheral T-cell lymphoma

  • Cutaneous T-cell lymphoma

  • Lymphomas

Biomarkers

  • Anaplastic lymphoma Kinase

  • B-lymphocyte antigen CD20

  • Paired box 5

  • Cluster of Differentiation 2

  • Cluster of Differentiation 2AP

  • Cluster of Differentiation 30

  • Cluster of Differentiation 4

  • Cluster of differentiation 45

  • Cluster of Differentiation 5

  • Cluster of Differentiation 56

  • Cluster of differentiation 7

  • Cluster of differentiation 8A

  • Complement component receptor 2

  • TIA1 Cytotoxic Granule Associated RNA Binding Protein

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim